- Home
- PEBK vs NVRO Comparison
PEBK vs NVRO Comparison
Compare PEBK & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBK
- NVRO
- Stock Information
- Founded
- PEBK 1912
- NVRO 2006
- Country
- PEBK United States
- NVRO United States
- Employees
- PEBK N/A
- NVRO N/A
- Industry
- PEBK Major Banks
- NVRO Medical/Dental Instruments
- Sector
- PEBK Finance
- NVRO Health Care
- Exchange
- PEBK Nasdaq
- NVRO Nasdaq
- Market Cap
- PEBK 169.6M
- NVRO 139.0M
- IPO Year
- PEBK N/A
- NVRO 2014
- Fundamental
- Price
- PEBK $29.00
- NVRO $5.15
- Analyst Decision
- PEBK
- NVRO Hold
- Analyst Count
- PEBK 0
- NVRO 14
- Target Price
- PEBK N/A
- NVRO $7.97
- AVG Volume (30 Days)
- PEBK 11.9K
- NVRO 599.4K
- Earning Date
- PEBK 02-11-2025
- NVRO 02-19-2025
- Dividend Yield
- PEBK 2.24%
- NVRO N/A
- EPS Growth
- PEBK 1.99
- NVRO N/A
- EPS
- PEBK 2.95
- NVRO N/A
- Revenue
- PEBK $79,995,000.00
- NVRO $419,146,000.00
- Revenue This Year
- PEBK N/A
- NVRO N/A
- Revenue Next Year
- PEBK N/A
- NVRO $0.50
- P/E Ratio
- PEBK $9.47
- NVRO N/A
- Revenue Growth
- PEBK 3.47
- NVRO N/A
- 52 Week Low
- PEBK $23.74
- NVRO $3.17
- 52 Week High
- PEBK $33.31
- NVRO $17.75
- Technical
- Relative Strength Index (RSI)
- PEBK 46.11
- NVRO 60.56
- Support Level
- PEBK $27.71
- NVRO $4.84
- Resistance Level
- PEBK $29.41
- NVRO $5.47
- Average True Range (ATR)
- PEBK 0.67
- NVRO 0.32
- MACD
- PEBK -0.03
- NVRO 0.07
- Stochastic Oscillator
- PEBK 38.28
- NVRO 73.22
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.